Cite
HARVARD Citation
Cefalù, A. et al. (2022). Efficacy and safety of lomitapide in familial chylomicronaemia syndrome. Atherosclerosis. pp. 13-19. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cefalù, A. et al. (2022). Efficacy and safety of lomitapide in familial chylomicronaemia syndrome. Atherosclerosis. pp. 13-19. [Online].